Analyze Diet

Topic:Vaccine

Vaccination in horses involves the administration of biological preparations designed to stimulate the equine immune system to recognize and combat specific pathogens. Vaccines are formulated to prevent or reduce the severity of infectious diseases that can affect equine health and performance. Common vaccines for horses include those for equine influenza, tetanus, equine herpesvirus, and West Nile virus. The administration schedule and type of vaccine can vary based on factors such as geographic location, age, and use of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in horses, as well as their impact on equine health management.
Antibody Responses Against Equine Influenza Virus Induced by Concurrent and by Consecutive Use of an Inactivated Equine Influenza Virus Vaccine and a Modified Live Equine Herpesvirus Type 1 Vaccine in Thoroughbred Racehorses.
Journal of equine veterinary science    August 7, 2020   Volume 94 103221 doi: 10.1016/j.jevs.2020.103221
Ohta M, Bannai H, Nemoto M, Kambayashi Y, Tamura N, Tsujimura K.An inactivated equine influenza virus (EIV) vaccine and a live equine herpesvirus type 1 (EHV-1) vaccine are usually administered concurrently to Thoroughbred racehorses in Japan. The objective of this study was to evaluate whether concurrent administration of an inactivated EIV vaccine and a live EHV-1 vaccine in Thoroughbred racehorses influences the antibody response against EIV. We compared the antibody response against EIV in horses administered both vaccines on the same day (Group A; n = 27) and the response in horses administered an inactivated EIV vaccine first and then a live EHV-1 v...
Genotype-specific neutralizing antibody titers against Japanese encephalitis virus genotypes 1 and 3 in horses immunized with a genotype 3 vaccine.
Clinical and experimental vaccine research    July 31, 2020   Volume 9, Issue 2 102-107 doi: 10.7774/cevr.2020.9.2.102
Kim HH, Yang DK, Ji M, Lee SK, Hyun BH.Japanese encephalitis is one of the most important mosquito-borne and zoonotic diseases in Asia and the Pacific region. Although the dominant Japanese encephalitis virus (JEV) genotype has shifted from G3 to G1 in Korea since 1990, a G3 strain (Anyang 300) has been used in vaccines for horses for almost 40 years. This study aimed to investigate the seroconversion rates and geometric mean titers (GMTs) of virus-neutralizing antibodies (VNAs) against JEV G1 and G3 in horses immunized with the G3 vaccine. Methods: Serum samples of 1,231 horses immunized with the Anyang 300 vaccine were collected ...
Serum Amyloid A (SAA) Concentration after Vaccination in Horses and Mules.
Journal of equine veterinary science    June 11, 2020   Volume 92 103165 doi: 10.1016/j.jevs.2020.103165
Duran MC, Dumrath CAC, Bartmann CP, Medina Torres CE, Moschos A, Goehring LS.Serum amyloid A (SAA) is a sensitive acute-phase response (APR) marker in equids. Prominent APRs with elevations of SAA concentrations ([SAA]) have been reported after vaccination. The authors hypothesized that vaccination with an inactivated EHV-1/-4 vaccine would cause increase in [SAA] and antibody responses and that higher [SAA] would be positively correlated with the antibody titer in both equids. Twelve Haflinger horses and 12 mules were included in this longitudinal prospective study. All horses and mules were vaccinated with a commercially available EHV-1/-4 vaccine. Blood was sampled ...
Evaluation of Three Different Vaccination Protocols against EHV1/EHV4 Infection in Mares: Double Blind, Randomized Clinical Trial.
Vaccines    June 1, 2020   Volume 8, Issue 2 268 doi: 10.3390/vaccines8020268
EHV1 and EHV4 are the most important herpesviruses in horses. Repeated cases of abortion in mares regularly vaccinated, prompted us to investigate the immune response after vaccination with the same inactivated vaccine, but with three different protocols. Eighteen mares were chosen and randomly divided in three study groups (G-G-G) and a control group (Ctrl). For serologic and PCR investigations nasal swabs, sera and blood were collected. The protocol used in G (4 doses) increased the titer recorded by ELISA and seroneutralization (SN). Poor agreement and no correlation were observed in titer ...
Assessment of Rabies Prophylaxis Cases in an Emergency Service.
Journal of emergency nursing    May 14, 2020   Volume 46, Issue 6 907-913 doi: 10.1016/j.jen.2020.03.014
Can FK, Tekin E, Sezen S, Clutter P.The aim of the present study was to evaluate the demographic characteristics, exposure features, and prophylactic care aspects of cases that presented to the emergency department of 1 state hospital in Turkey between 2013 and 2017 because of the risk of rabies contact. Methods: Data from the retrospective cohort study were obtained from ED records of Erzurum Palandöken State Hospital between August 2013 and June 2017 regarding patients presenting to emergency service after the risk of rabies contact. Evaluation forms included demographic characteristics of the patients, contact type, contacte...
Equine influenza vaccination as reported by horse owners and factors influencing their decision to vaccinate or not.
Preventive veterinary medicine    May 12, 2020   Volume 180 105011 doi: 10.1016/j.prevetmed.2020.105011
Bambra W, Daly JM, Kendall NR, Gardner DS, Brennan M, Kydd JH.Equine influenza virus is a highly contagious respiratory pathogen that causes pyrexia, anorexia, lethargy and coughing in immunologically naïve horses. Vaccines against equine influenza are available and vaccination is mandatory for horses that participate in affiliated competitions, but this group forms a small proportion of the total horse population. The aims of this study were to: i) identify the equine influenza vaccination rate as reported in 2016 by horse owners in the United Kingdom (UK); ii) examine the demographics of owners and horses which were associated with significantly lower...
Prevention of respiratory infections with alpha- and gamma-herpesviruses in weanling foals by using a modified live intra-nasal equine influenza vaccine.
The Canadian veterinary journal = La revue veterinaire canadienne    May 2, 2020   Volume 61, Issue 5 517-520 
Salco R, Bowers J, Hernandez V, Barnum S, Pusterla N.This study aimed to determine if the administration of a modified live equine influenza virus vaccine (FluAvert) to foals would positively impact their health and reduce colonization of their upper airways with equine herpesviruses (EHV) during the weaning period. A single dose of FluAvert was given to 20 healthy foals 7 days prior to being weaned; 20 healthy foals served as unvaccinated controls. Nasal secretions and blood were collected before vaccination, the day of weaning, and weekly thereafter for 3 weeks. Nasal secretions were tested by quantitative polymerase chain reaction (qPCR) for ...
Epidemiological and virological findings during an outbreak of equine influenza in Uruguay in 2018.
Revue scientifique et technique (International Office of Epizootics)    April 15, 2020   Volume 38, Issue 3 737-749 doi: 10.20506/rst.38.3.3023
Castro ER, Perez R, Rodriguez S, Bassetti L, Negro R, Vidal R.Equine influenza is one of the major respiratory infectious diseases in horses. In 2018, equine influenza virus (EIV) was confirmed as the cause of outbreaks of respiratory disease in horses in Chile and Argentina. In the same year, for the first time in Uruguay, EIV infection was confirmed by isolation and molecular analysis to be the cause of respiratory disease among hundreds of clinically affected thoroughbred horses in training and racing facilities. The virus was detected in nasopharyngeal swabs by a pan-reactive influenza type A realtime reverse transcription polymerase chain reaction (...
Molecular detection, histopathological analysis, and immunohistochemical characterization of equine infectious anemia virus in naturally infected equids.
Archives of virology    April 7, 2020   Volume 165, Issue 6 1333-1342 doi: 10.1007/s00705-020-04616-4
Bueno BL, Câmara RJF, Moreira MVL, Galinari GCF, Souto FM, Victor RM, Bicalho JM, Ecco R, Dos Reis JKP.Equine infectious anemia (EIA), a disease caused by equine infectious anemia virus (EIAV), is considered an obstacle to the development of the horse industry. There is no treatment or vaccine available for EIA, and its pathogenesis, as well as the immune response against the virus, is not fully understood. Therefore, an immunohistochemistry assay was developed for the detection of viral antigens in tissues of equids naturally infected with EIAV. Sections of organs of six equids from Apodi-RN, Brazil, that tested positive for EIA by serological tests (ELISA and AGID) were fixed in 10% formalin ...
Identification of genes required for the fitness of Streptococcus equi subsp. equi in whole equine blood and hydrogen peroxide.
Microbial genomics    March 31, 2020   Volume 6, Issue 4 e000362 doi: 10.1099/mgen.0.000362
Charbonneau ARL, Taylor E, Mitchell CJ, Robinson C, Cain AK, Leigh JA, Maskell DJ, Waller AS.The availability of next-generation sequencing techniques provides an unprecedented opportunity for the assignment of gene function. subspecies is the causative agent of strangles in horses, one of the most prevalent and important diseases of equids worldwide. However, the live attenuated vaccines that are utilized to control this disease cause adverse reactions in some animals. Here, we employ transposon-directed insertion-site sequencing (TraDIS) to identify genes that are required for the fitness of in whole equine blood or in the presence of HO to model selective pressures exerted by th...
A Brief Introduction to Equine Influenza and Equine Influenza Viruses.
Methods in molecular biology (Clifton, N.J.)    March 15, 2020   Volume 2123 355-360 doi: 10.1007/978-1-0716-0346-8_26
Chambers TM.Equine influenza virus (EIV) is a common respiratory pathogen of horses and other equids in most parts of the world. EIV are Type A influenza viruses and two subtypes are known: H3N8 and H7N7. Both are believed to have evolved from avian influenza virus ancestors. The H3N8 subtype circulates widely, but the H7N7 subtype is thought to be extinct. The clinical disease in horses, caused by either subtype, is an upper respiratory infection of varying severity depending upon the immune status of the individual animal. It is not normally life-threatening in itself except in very young foals; however...
Challenges to develop an equine herpesvirus vaccine in China.
The Journal of infection    February 1, 2020   Volume 80, Issue 5 578-606 doi: 10.1016/j.jinf.2020.01.013
Ji C, Cai S, Lu G, Zhang G.No abstract available
Plant-produced chimeric virus-like particles – a new generation vaccine against African horse sickness.
BMC veterinary research    December 3, 2019   Volume 15, Issue 1 432 doi: 10.1186/s12917-019-2184-2
Rutkowska DA, Mokoena NB, Tsekoa TL, Dibakwane VS, O'Kennedy MM.African horse sickness (AHS) is a severe arthropod-borne viral disease of equids, with a mortality rate of up to 95% in susceptible naïve horses. Due to safety concerns with the current live, attenuated AHS vaccine, alternate safe and effective vaccination strategies such as virus-like particles (VLPs) are being investigated. Transient plant-based expression systems are a rapid and highly scalable means of producing such African horse sickness virus (AHSV) VLPs for vaccine purposes. Results: In this study, we demonstrated that transient co-expression of the four AHSV capsid proteins in agroin...
A study with a commercial vaccine against Lyme borreliosis in horses using two different vaccination schedules: Characterization of the humoral immune response.
Vaccine    October 18, 2019   Volume 37, Issue 49 7207-7212 doi: 10.1016/j.vaccine.2019.09.087
Knödlseder JM, Fell SF, Straubinger RK.A total of 143 horses were included in a study to test a commercial vaccine against Lyme borreliosis. The vaccine contained three different antigens (outer surface protein A, OspA) to prevent the infection with spirochetes - B.burgdorferi sensu stricto, B. afzelii and B. garinii. Horses in Group A (49 animals) received two vaccinations on days 0 and 14 and a booster on day 365, whereas 50 horses in Group B received an additional booster vaccination on day 180. Group C (44 animals) was not immunized. Total antibody levels and specific OspA antibody responses were assessed quantitatively and qua...
Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
Vaccine    October 16, 2019   Volume 38, Issue 2 388-398 doi: 10.1016/j.vaccine.2019.09.106
Kydd JH, Hannant D, Robinson RS, Bryant N, Osterrieder N.Equid herpesvirus-1 (EHV-1) causes respiratory and neurological disease and late gestation abortion in pregnant mares. Current vaccines contain either inactivated or live EHV-1, but fail to provide complete clinical or virological protection, namely prevention of nasopharyngeal shedding and cell-associated viraemia. Thus, the development of novel products, such as modified live virus (MLV) vaccines which stimulate virus-specific, humoral and cell mediated immune responses more effectively remains a priority. Two groups of weaned foals (n = 6 each group) were used in a longitudinal, prospec...
A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus.
Viruses    October 11, 2019   Volume 11, Issue 10 933 doi: 10.3390/v11100933
Blanco-Lobo P, Rodriguez L, Reedy S, Oladunni FS, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L.Vaccination remains the most effective approach for preventing and controlling equine influenza virus (EIV) in horses. However, the ongoing evolution of EIV has increased the genetic and antigenic differences between currently available vaccines and circulating strains, resulting in suboptimal vaccine efficacy. As recommended by the World Organization for Animal Health (OIE), the inclusion of representative strains from clade 1 and clade 2 Florida sublineages of EIV in vaccines may maximize the protection against presently circulating viral strains. In this study, we used reverse genetics tech...
Multifocal outbreak of equine influenza in vaccinated horses in Argentina in 2018: Epidemiological aspects and molecular characterisation of the involved virus strains.
Equine veterinary journal    October 4, 2019   Volume 52, Issue 3 420-427 doi: 10.1111/evj.13176
Olguin-Perglione C, Vissani MA, Alamos F, Tordoya MS, Barrandeguy M.Equine influenza is an important cause of respiratory disease of horses worldwide. The equine influenza virus (EIV) undergoes antigenic drift through the accumulation of amino acid substitutions in the viral proteins, which may lead to vaccine breakdown. Objective: To describe the epidemiological findings and the molecular characteristics of the EIV detected during the multifocal outbreak that occurred in Argentina between March and July 2018 and evidence a vaccine breakdown. Methods: Observational, descriptive study. Methods: Virus was detected in nasopharyngeal swabs using real-time reverse ...
African Horse Sickness: A Review of Current Understanding and Vaccine Development.
Viruses    September 11, 2019   Volume 11, Issue 9 doi: 10.3390/v11090844
Dennis SJ, Meyers AE, Hitzeroth II, Rybicki EP.African horse sickness is a devastating disease that causes great suffering and many fatalities amongst horses in sub-Saharan Africa. It is caused by nine different serotypes of the orbivirus African horse sickness virus (AHSV) and it is spread by Culicoid midges. The disease has significant economic consequences for the equine industry both in southern Africa and increasingly further afield as the geographic distribution of the midge vector broadens with global warming and climate change. Live attenuated vaccines (LAV) have been used with relative success for many decades but carry the risk o...
Antigenicity assessment of the Theileria equi merozoite antigen (EMA-2) expressed in Pichia pastoris in mice and horses.
Experimental parasitology    September 5, 2019   Volume 206 107757 doi: 10.1016/j.exppara.2019.107757
Vianna AM, Santos AC, Cunha RC, de Souza Stori de Lara AP, Weege GB, Leivas Leite FP.Equine theileriosis is a severe equine disease caused by the protozoan Theileria equi, which is prevalent in tropical and subtropical areas. In this study, a recombinant equi merozoite antigen-2 (rEMA-2) of T. equi was used as an immunogen. Two groups of 10 mice each were divided into control and vaccinated groups. Sixty mares seronegative for theileriosis were divided in two groups, one vaccinated and another group as a control animal. Mice and mares of the vaccinated groups were inoculated with 150 μL of the vaccine containing 50 μg of rEMA-2 and 2 mL of the vaccine containing 200 ...
Evaluation of safety, humoral immune response and faecal shedding in horses inoculated with a modified-live bovine coronavirus vaccination.
Equine veterinary education    August 31, 2019   Volume 32, Issue Suppl 11 33-36 doi: 10.1111/eve.13175
Prutton JSW, Barnum S, Pusterla N.Equine coronavirus (ECoV) is considered an emerging enteric virus with reported morbidity rates ranging from 10 to 83% and fatality rates ranging from 7 to 27% in adult horses; a vaccine for ECoV is currently not available. This study investigated the safety, humoral response and viral shedding in horses inoculated with a commercially available modified-live bovine coronavirus (BCoV) vaccine. Twelve healthy adult horses were vaccinated twice, 3 weeks apart, either orally, intranasally or intrarectally. Two healthy unvaccinated horses served as sentinel controls. Following each vaccine adminis...
Equine influenza outbreaks in the UK: a practical approach to prevention.
The Veterinary record    August 20, 2019   Volume 185, Issue 7 198-200 doi: 10.1136/vr.l5185
With outbreaks of equine influenza continuing to be reported in the UK, Richard Newton and Fleur Whitlock of the Animal Health Trust discusses practical steps that vets can promote and practise to reduce the risk of the virus spreading.
Epizootiological investigation of equine herpesvirus type 1 infection among Japanese racehorses before and after the replacement of an inactivated vaccine with a modified live vaccine.
BMC veterinary research    August 6, 2019   Volume 15, Issue 1 280 doi: 10.1186/s12917-019-2036-0
Bannai H, Tsujimura K, Nemoto M, Ohta M, Yamanaka T, Kokado H, Matsumura T.Equine herpesvirus type 1 (EHV-1) infection is a major cause of pyrexias in winter among Japanese racehorses. In 2014-2015, the Japan Racing Association (JRA) changed the EHV-1 vaccine from an inactivated vaccine to a live vaccine (both produced by Nisseiken). To evaluate the effect of changing the vaccines, the capacities of these vaccines to induce virus-neutralizing (VN) antibodies were compared, and an epizootiological investigation of EHV-1 was performed at the JRA Ritto Training Center during epizootic periods from 2010-2011 to 2016-2017. Results: Three-year-old horses that received the ...
Cross-sectional survey of pet ownership, veterinary service utilisation, and pet-related expenditures in New Zealand.
New Zealand veterinary journal    August 4, 2019   Volume 67, Issue 6 306-314 doi: 10.1080/00480169.2019.1645626
Gates MC, Walker J, Zito S, Dale A. To describe the demographics of and predictors for pet ownership, reasons for visiting a veterinarian, and pet-related expenditure in pet owners in New Zealand. A cross-sectional online survey was conducted from 18-22 June 2015 using a permission-based panel of New Zealand residents aged ≥18 years. Questions included demographics of respondents, number of pets and reasons for owning or not owning pets, number of visits and reasons for visiting a veterinarian, and pet-related expenditure. Of the 1,572 respondents who completed the survey, 1,013 (64.4%) owned ≥1 pet. Of these, 443 owned d...
Australian Rotavirus Surveillance Program: Annual Report, 2017.
Communicable diseases intelligence (2018)    July 16, 2019   Volume 43 doi: 10.33321/cdi.2019.43.28
Roczo-Farkas S, Cowley D, Bines JE.This report, from the Australian Rotavirus Surveillance Program and collaborating laboratories Australia-wide, describes the rotavirus genotypes identified in children and adults with acute gastroenteritis during the period 1 January to 31 December 2017. During this period, 2,285 faecal specimens were referred for rotavirus G and P genotype analysis, including 1,103 samples that were confirmed as rotavirus positive. Of these, 1,014/1,103 were wildtype rotavirus strains and 89/1,103 were identified as rotavirus vaccine-like. Genotype analysis of the 1,014 wildtype rotavirus samples from both ch...
Treatment Options for Melanoma of Gray Horses.
The Veterinary clinics of North America. Equine practice    July 8, 2019   Volume 35, Issue 2 311-325 doi: 10.1016/j.cveq.2019.04.003
MacKay RJ.All gray horses inherited a single gene mutation, STX17G, that unbalances melanocyte behavior to cause graying and propensities to develop vitiligo and melanoma. The coat color genes ASIPa and MC1RE add risk such that relative likelihood of melanoma based on pregraying coat color is black > bay > chestnut. Melanomas begin at about 4 years. Locoregional control of melanoma masses depends on surgical removal and/or intralesional chemotherapy (possibly with adjunctive hyperthermia or electroporation). Systemic treatment is not evidence based but immunomodulators (cimetidine, levamisole) and ...
Towards a vaccine for equine encephalitis viruses.
Nature reviews. Drug discovery    July 4, 2019   Volume 18, Issue 7 500 doi: 10.1038/d41573-019-00095-8
Crunkhorn S.No abstract available
Serological responses of Australian horses using a commercial duplex indirect ELISA following vaccination against strangles.
Australian veterinary journal    June 27, 2019   Volume 97, Issue 7 220-224 doi: 10.1111/avj.12825
El-Hage CM, Bannai H, Wiethoelter AK, Firestone SM, Heislers CM, Allen JL, Waller AS, Gilkerson JR.To determine the nature of serological responses in Australian horses using a commercial duplex indirect ELISA (iELISA) following vaccination against strangles. Methods: A group (n = 19) of client-owned horses from five properties were recruited to receive a primary course of a Streptococcus equi subsp. equi (S. equi) extract vaccine. Serological responses were determined by duplex iELISA incorporating S. equi-specific fragments of two cell wall proteins, SEQ2190 and SeM (antigens (Ag) A and C, respectively). Methods: The horses were administered a primary strangles vaccination course. Blood w...
A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain.
Archives of virology    June 21, 2019   Volume 164, Issue 9 2355-2358 doi: 10.1007/s00705-019-04328-4
Nemoto M, Yamayoshi S, Bannai H, Tsujimura K, Kokado H, Kawaoka Y, Yamanaka T.Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid subst...
Isolation and characterization of equine influenza virus (H3N8) from an equine influenza outbreak in Malaysia in 2015.
Transboundary and emerging diseases    May 22, 2019   Volume 66, Issue 5 1884-1893 doi: 10.1111/tbed.13218
Toh X, Soh ML, Ng MK, Yap SC, Harith N, Fernandez CJ, Huangfu T.Equine influenza is a major cause of respiratory infections in horses and can spread rapidly despite the availability of commercial vaccines. In this study, we carried out molecular characterization of Equine Influenza Virus (EIV) isolated from the Malaysian outbreak in 2015 by sequencing of the HA and NA gene segments using Sanger sequencing. The nucleotide and amino acid sequences of HA and NA were compared with representative Florida clade 1 and clade 2 strains using phylogenetic analysis. The Florida clade 1 viruses identified in this outbreak revealed numerous amino acid substitutions in ...
[Vaccinovigilance: Reported adverse reactions of immunological veterinary medicinal products in 2018].
Schweizer Archiv fur Tierheilkunde    May 9, 2019   Volume 161, Issue 5 299-306 doi: 10.17236/sat00206
Rogger P, Herrmann N, Ottiger H.The registration of adverse events after the use of immunological veterinary medicinal products (VMP) is the aim of the vaccinovigilance reporting system in Switzerland. Adverse events comprise suspected adverse reactions and lack of expected efficacy. Since the Institute of virology and immunology (IVI) is the competent authority for the regulation of immunological VMP in Switzerland, the reporting system is administrated by the IVI. In 2018, 162 reports concerning authorized immunological VMP were received. While most of the reports were submitted by the marketing authorization holders (79%)...
1 5 6 7 8 9 29